The week in review


Dr Bav Manoharan makes a motion at the AMA's 2019 AGM. Image AMA Media via Twitter.
Dr Bav Manoharan makes a motion at the AMA's 2019 AGM. Image AMA Media via Twitter.

As flu grips the country, it’s been a busy week in pharmacy…

There have been significant concerns about availability of the flu vaccine, with newly reappointed Health Minister Greg Hunt saying that more vaccines are on their way into the country; the Guild‘s John Dowling says one solution to the shortage could be giving pharmacists in more jurisdictions access to flu vaccines under the National Immunisation Program.

The Australian Medical Association passed an urgency motion that the organisation should call for an immediate stop to the Queensland pharmacy prescribing trial… a move dismissed as “cheap” by Pharmacy Guild Queensland branch president Trent Twomey, who urged the GP organisation to work with the Guild instead. Meanwhile, the authors of a paper on pharmacy point-of-care screening encouraged GPs to “get onboard” with the concept.

We looked at why some pharmacy owners had recently been reprimanded by the Victorian Pharmacy Authority; and the barriers that still stymie the availability of naloxone through community pharmacy.

The Consumers Health Forum called for a radical revamp of the way Australia’s pharmacists work… including getting them out of pharmacies; while in the UK, one supermarket chain is about to trial “click and collect” lockers for dispensed medicines.

We learned that elderly patients with heart failure who see a pharmacist once a week are more likely to adhere to their medication regime and be more active

And we found out what AJP readers – and the Guild and PSA – thought about professional services pharmacists.

Previous All the way to the bank
Next Poll: Professional services and pharmacists

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.